These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26680206)

  • 21. Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Chao ML; Guo J; Cheng WL; Zhu XY; She ZG; Huang Z; Ji Y; Li H
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 28007744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.
    Mihailovic PM; Lio WM; Yano J; Zhao X; Zhou J; Chyu KY; Shah PK; Cercek B; Dimayuga PC
    PLoS One; 2017; 12(11):e0187432. PubMed ID: 29091929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
    Orekhov AN; Poznyak AV; Sobenin IA; Nikifirov NN; Ivanova EA
    Curr Neuropharmacol; 2020; 18(11):1064-1075. PubMed ID: 31744449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial autophagic flux hampers atherosclerotic lesion development.
    Kheloufi M; Vion AC; Hammoutene A; Poisson J; Lasselin J; Devue C; Pic I; Dupont N; Busse J; Stark K; Lafaurie-Janvore J; Barakat AI; Loyer X; Souyri M; Viollet B; Julia P; Tedgui A; Codogno P; Boulanger CM; Rautou PE
    Autophagy; 2018; 14(1):173-175. PubMed ID: 29157095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
    Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
    J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment.
    Blin MG; Bachelier R; Fallague K; Moussouni K; Aurrand-Lions M; Fernandez S; Guillet B; Robert S; Foucault-Bertaud A; Bardin N; Blot-Chabaud M; Dignat-George F; Leroyer AS
    J Mol Cell Cardiol; 2019 May; 130():76-87. PubMed ID: 30928429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective autophagy in vascular smooth muscle cells enhances cell death and atherosclerosis.
    Osonoi Y; Mita T; Azuma K; Nakajima K; Masuyama A; Goto H; Nishida Y; Miyatsuka T; Fujitani Y; Koike M; Mitsumata M; Watada H
    Autophagy; 2018; 14(11):1991-2006. PubMed ID: 30025494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis.
    Li W; Sultana N; Siraj N; Ward LJ; Pawlik M; Levy E; Jovinge S; Bengtsson E; Yuan XM
    J Cell Mol Med; 2016 Sep; 20(9):1664-72. PubMed ID: 27079462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined Plasma and Tissue Proteomic Study of Atherogenic Model Mouse: Approach To Elucidate Molecular Determinants in Atherosclerosis Development.
    Hanzawa H; Sakamoto T; Kaneko A; Manri N; Zhao Y; Zhao S; Tamaki N; Kuge Y
    J Proteome Res; 2015 Oct; 14(10):4257-69. PubMed ID: 26323832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
    Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
    FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathelicidin Antimicrobial Peptide Levels in Atherosclerosis and Myocardial Infarction in Mice and Human.
    Höpfinger A; Schmid A; Karrasch T; Pankuweit S; Schäffler A; Grote K
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of miRNA-155 in carotid atherosclerotic plaques of apolipoprotein E knockout (ApoE
    Ma J; Yang S; Ma A; Pan X; Wang H; Li N; Liu S; Wu M
    Int Immunopharmacol; 2017 May; 46():70-74. PubMed ID: 28273556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture.
    Bond AR; Jackson CL
    J Biomed Biotechnol; 2011; 2011():379069. PubMed ID: 21076539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the antimicrobial peptide LL-37 in human atherosclerosis.
    Edfeldt K; Agerberth B; Rottenberg ME; Gudmundsson GH; Wang XB; Mandal K; Xu Q; Yan ZQ
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1551-7. PubMed ID: 16645154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.
    Bode N; Grebe A; Kerksiek A; Lütjohann D; Werner N; Nickenig G; Latz E; Zimmer S
    Biochem Biophys Res Commun; 2016 Sep; 478(1):356-362. PubMed ID: 27416761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients with Liver Diseases and Acts as a Protective Factor during Mouse Liver Injury.
    Wertenbruch S; Drescher H; Grossarth V; Kroy D; Giebeler A; Erschfeld S; Heinrichs D; Soehnlein O; Trautwein C; Brandenburg LO; Streetz K
    Digestion; 2015; 91(4):307-17. PubMed ID: 25998843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vinexin β Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor κB Inflammatory Axis.
    Guan H; Cheng WL; Guo J; Chao ML; Zhang Y; Gong J; Zhu XY; She ZG; Huang Z; Li H
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28209562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.